Literature DB >> 15504247

Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue.

Takao Inoue1, Hiroaki Kataoka, Kouichiro Goto, Koki Nagaike, Ko Igami, Daiji Naka, Naomi Kitamura, Keiji Miyazawa.   

Abstract

c-Met is a high-affinity receptor for hepatocyte growth factor (HGF) and plays a crucial role in embryonic development, as well as in the process of tissue repair. Overexpression and amplification of c-Met are often observed in various cancer tissues, especially in gastric carcinoma. It has, however, been unclear whether the overexpression leads to activation of the c-Met receptor. To address this point, we prepared an antibody (anti-phospho-Met) which specifically recognizes c-Met that is phosphorylated at Y1235, a major phosphorylation site of c-Met. Normal as well as cancerous gastric tissue was positive for anti-total-Met staining, whereas only cancerous tissue was strongly positive for anti-phospho-Met staining; cells near the basal layer were moderately positive, and the proliferative zone in normal tissue was only weakly positive. Among cancerous tissues from seven patients examined in the present study, those from six patients were strongly positive for phospho-Met staining. These results indicate that c-Met is actually activated in gastric carcinoma tissue, and may trigger proliferation/anti-apoptotic signals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504247     DOI: 10.1111/j.1349-7006.2004.tb02185.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  31 in total

Review 1.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

Review 2.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

Review 3.  Current advances of targeting HGF/c-Met pathway in gastric cancer.

Authors:  Aristomenis Anestis; Ilianna Zoi; Michalis V Karamouzis
Journal:  Ann Transl Med       Date:  2018-06

Review 4.  Molecular targeted agents for gastric and gastroesophageal junction cancer.

Authors:  Takashi Oshima; Munetaka Masuda
Journal:  Surg Today       Date:  2011-11-30       Impact factor: 2.549

Review 5.  Targeting receptor tyrosine kinases in gastric cancer.

Authors:  Asahiro Morishita; Jian Gong; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

6.  Expression of human kallikrein 1-related peptidase 4 (KLK4) and MET phosphorylation in prostate cancer tissue: immunohistochemical analysis.

Authors:  Shoichiro Mukai; Kenji Yorita; Koji Yamasaki; Takahiro Nagai; Toyoharu Kamibeppu; Satoru Sugie; Kazutaka Kida; Chie Onizuka; Hiromasa Tsukino; Toshio Kamimura; Toshiyuki Kamoto; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2015-04-11       Impact factor: 4.174

7.  MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells.

Authors:  Chin-Tung Chen; Hyaehwan Kim; David Liska; Sizhi Gao; James G Christensen; Martin R Weiser
Journal:  Mol Cancer Ther       Date:  2012-01-11       Impact factor: 6.261

Review 8.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

Authors:  Roya Navab; Jiang Liu; Isolde Seiden-Long; Warren Shih; Ming Li; Bizhan Bandarchi; Yan Chen; Davina Lau; Yen-Fen Zu; Dave Cescon; Chang Qi Zhu; Shawna Organ; Emin Ibrahimov; Dina Ohanessian; Ming-Sound Tsao
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

10.  Loss of HGF activator inhibits foveolar hyperplasia induced by oxyntic atrophy without altering gastrin levels.

Authors:  Yukinori Yamagata; Susumu Aikou; Tsuyoshi Fukushima; Hiroaki Kataoka; Yasuyuki Seto; Hiroyasu Esumi; Michio Kaminishi; James R Goldenring; Sachiyo Nomura
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.